Logo image of KRO

KRONOS WORLDWIDE INC (KRO) Stock Fundamental Analysis

NYSE:KRO - New York Stock Exchange, Inc. - US50105F1057 - Common Stock - Currency: USD

6.14  +0.06 (+0.99%)

After market: 6.14 0 (0%)

Fundamental Rating

4

Overall KRO gets a fundamental rating of 4 out of 10. We evaluated KRO against 85 industry peers in the Chemicals industry. KRO has a medium profitability rating, but doesn't score so well on its financial health evaluation. KRO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year KRO was profitable.
KRO had a positive operating cash flow in the past year.
KRO had positive earnings in 4 of the past 5 years.
In the past 5 years KRO always reported a positive cash flow from operatings.
KRO Yearly Net Income VS EBIT VS OCF VS FCFKRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

With a decent Return On Assets value of 4.94%, KRO is doing good in the industry, outperforming 75.29% of the companies in the same industry.
With a decent Return On Equity value of 11.36%, KRO is doing good in the industry, outperforming 78.82% of the companies in the same industry.
The Return On Invested Capital of KRO (7.83%) is better than 71.76% of its industry peers.
Industry RankSector Rank
ROA 4.94%
ROE 11.36%
ROIC 7.83%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
KRO Yearly ROA, ROE, ROICKRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

KRO has a Profit Margin of 5.07%. This is in the better half of the industry: KRO outperforms 65.88% of its industry peers.
In the last couple of years the Profit Margin of KRO has declined.
Looking at the Operating Margin, with a value of 7.92%, KRO is in line with its industry, outperforming 47.06% of the companies in the same industry.
In the last couple of years the Operating Margin of KRO has declined.
KRO has a Gross Margin of 20.79%. This is in the lower half of the industry: KRO underperforms 65.88% of its industry peers.
In the last couple of years the Gross Margin of KRO has declined.
Industry RankSector Rank
OM 7.92%
PM (TTM) 5.07%
GM 20.79%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
KRO Yearly Profit, Operating, Gross MarginsKRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KRO is destroying value.
Compared to 1 year ago, KRO has about the same amount of shares outstanding.
KRO has less shares outstanding than it did 5 years ago.
The debt/assets ratio for KRO is higher compared to a year ago.
KRO Yearly Shares OutstandingKRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
KRO Yearly Total Debt VS Total AssetsKRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.90 indicates that KRO is not a great score, but indicates only limited risk for bankruptcy at the moment.
KRO has a Altman-Z score of 1.90. This is comparable to the rest of the industry: KRO outperforms 50.59% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that KRO is somewhat dependend on debt financing.
KRO has a Debt to Equity ratio (0.56) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z 1.9
ROIC/WACC0.82
WACC9.5%
KRO Yearly LT Debt VS Equity VS FCFKRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

KRO has a Current Ratio of 2.62. This indicates that KRO is financially healthy and has no problem in meeting its short term obligations.
KRO's Current ratio of 2.62 is fine compared to the rest of the industry. KRO outperforms 72.94% of its industry peers.
KRO has a Quick Ratio of 2.62. This is a bad value and indicates that KRO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.99, KRO is not doing good in the industry: 62.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.62
Quick Ratio 0.99
KRO Yearly Current Assets VS Current LiabilitesKRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

KRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 217.39%, which is quite impressive.
KRO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.83% yearly.
Looking at the last year, KRO shows a quite strong growth in Revenue. The Revenue has grown by 10.42% in the last year.
The Revenue has been growing slightly by 1.74% on average over the past years.
EPS 1Y (TTM)217.39%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%128.57%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%2.3%

3.2 Future

KRO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 97.12% yearly.
The Revenue is expected to grow by 4.76% on average over the next years.
EPS Next Y343.28%
EPS Next 2Y151.25%
EPS Next 3Y97.12%
EPS Next 5YN/A
Revenue Next Year-2.39%
Revenue Next 2Y4.32%
Revenue Next 3Y4.76%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRO Yearly Revenue VS EstimatesKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
KRO Yearly EPS VS EstimatesKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.74, which indicates a rather expensive current valuation of KRO.
KRO's Price/Earnings is on the same level as the industry average.
KRO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.04, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 5.40, the valuation of KRO can be described as very cheap.
Based on the Price/Forward Earnings ratio, KRO is valued cheaper than 97.65% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of KRO to the average of the S&P500 Index (37.64), we can say KRO is valued rather cheaply.
Industry RankSector Rank
PE 22.74
Fwd PE 5.4
KRO Price Earnings VS Forward Price EarningsKRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

90.59% of the companies in the same industry are more expensive than KRO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.65
KRO Per share dataKRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

KRO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KRO's earnings are expected to grow with 97.12% in the coming years.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y151.25%
EPS Next 3Y97.12%

4

5. Dividend

5.1 Amount

KRO has a Yearly Dividend Yield of 3.29%.
In the last 3 months the price of KRO has falen by -20.05%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.63, KRO pays a bit more dividend than its industry peers.
KRO's Dividend Yield is a higher than the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 3.29%

5.2 History

The dividend of KRO decreases each year by -7.80%.
KRO has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-7.8%
Div Incr Years0
Div Non Decr Years0
KRO Yearly Dividends per shareKRO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

KRO pays out 40.64% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP40.64%
EPS Next 2Y151.25%
EPS Next 3Y97.12%
KRO Yearly Income VS Free CF VS DividendKRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
KRO Dividend Payout.KRO Dividend Payout, showing the Payout Ratio.KRO Dividend Payout.PayoutRetained Earnings

KRONOS WORLDWIDE INC

NYSE:KRO (7/25/2025, 8:04:00 PM)

After market: 6.14 0 (0%)

6.14

+0.06 (+0.99%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners16.98%
Inst Owner Change0.06%
Ins Owners0.14%
Ins Owner Change0.07%
Market Cap706.35M
Analysts46.67
Price Target8.93 (45.44%)
Short Float %6.05%
Short Ratio5.51
Dividend
Industry RankSector Rank
Dividend Yield 3.29%
Yearly Dividend0.48
Dividend Growth(5Y)-7.8%
DP40.64%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-09 2025-06-09 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-97.85%
Min EPS beat(2)-188.88%
Max EPS beat(2)-6.81%
EPS beat(4)1
Avg EPS beat(4)-65.09%
Min EPS beat(4)-188.88%
Max EPS beat(4)11.47%
EPS beat(8)3
Avg EPS beat(8)3.68%
EPS beat(12)4
Avg EPS beat(12)-10.3%
EPS beat(16)7
Avg EPS beat(16)-2.19%
Revenue beat(2)0
Avg Revenue beat(2)-9.26%
Min Revenue beat(2)-15.25%
Max Revenue beat(2)-3.28%
Revenue beat(4)0
Avg Revenue beat(4)-10.76%
Min Revenue beat(4)-15.74%
Max Revenue beat(4)-3.28%
Revenue beat(8)2
Avg Revenue beat(8)-5.54%
Revenue beat(12)5
Avg Revenue beat(12)-2.59%
Revenue beat(16)7
Avg Revenue beat(16)-1.48%
PT rev (1m)7.14%
PT rev (3m)-12.5%
EPS NQ rev (1m)6.94%
EPS NQ rev (3m)-21.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.26%
Valuation
Industry RankSector Rank
PE 22.74
Fwd PE 5.4
P/S 0.37
P/FCF N/A
P/OCF 52.71
P/B 0.83
P/tB 0.84
EV/EBITDA 5.65
EPS(TTM)0.27
EY4.4%
EPS(NY)1.14
Fwd EY18.51%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.12
OCFY1.9%
SpS16.5
BVpS7.36
TBVpS7.34
PEG (NY)0.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.94%
ROE 11.36%
ROCE 9.92%
ROIC 7.83%
ROICexc 7.94%
ROICexgc 7.96%
OM 7.92%
PM (TTM) 5.07%
GM 20.79%
FCFM N/A
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-13.41%
ROICexcg growth 5Y-3.71%
ROICexc growth 3Y-13.47%
ROICexc growth 5Y-3.75%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
F-Score5
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Debt/EBITDA 2.18
Cap/Depr 53.8%
Cap/Sales 1.94%
Interest Coverage 2.97
Cash Conversion 6.13%
Profit Quality N/A
Current Ratio 2.62
Quick Ratio 0.99
Altman-Z 1.9
F-Score5
WACC9.5%
ROIC/WACC0.82
Cap/Depr(3y)85.77%
Cap/Depr(5y)95.93%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)217.39%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%128.57%
EPS Next Y343.28%
EPS Next 2Y151.25%
EPS Next 3Y97.12%
EPS Next 5YN/A
Revenue 1Y (TTM)10.42%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%2.3%
Revenue Next Year-2.39%
Revenue Next 2Y4.32%
Revenue Next 3Y4.76%
Revenue Next 5YN/A
EBIT growth 1Y822.6%
EBIT growth 3Y-13.2%
EBIT growth 5Y-3.37%
EBIT Next Year64.74%
EBIT Next 3Y30.37%
EBIT Next 5YN/A
FCF growth 1Y68.76%
FCF growth 3Y-33.75%
FCF growth 5Y-16.38%
OCF growth 1Y241.05%
OCF growth 3Y-29.45%
OCF growth 5Y-14.67%